Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Work
Year: 2001
Type: article
Abstract: Infliximab is a humanized antibody against tumor necrosis factor α (TNF-α) that is used in the treatment of Crohn's disease and rheumatoid arthritis. Approximately 147,000 patients throughout the worl... more
Source: New England Journal of Medicine
Authors Joseph Keane, Sharon K. Gershon, Robert P. Wise, Elizabeth Mirabile‐Levens, John Kasznica +3 more
Institutions Pulmonary Associates, Center for Biologics Evaluation and Research, Food and Drug Administration, Boston University, United States Food and Drug Administration
Cites: 37
Cited by: 3,656
Related to: 10
FWCI: 125.2
Citation percentile (by year/subfield): 99.98
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze